Catalyst Pharmaceuticals
Trade Catalyst Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E.
CPRX Key Statistics
Stock Snapshot
Catalyst Pharmaceuticals(CPRX) stock is priced at $24.82, giving the company a market capitalization of 3.05B. It carries a P/E multiple of 14.81.
On 2026-04-13, Catalyst Pharmaceuticals(CPRX) stock opened at $25.54, reached a high of —, and a low of —.
Catalyst Pharmaceuticals(CPRX) shares are trading with a volume of 0, against a daily average of 1.08M.
During the past year, Catalyst Pharmaceuticals(CPRX) stock moved between $19.05 at its lowest and $26.58 at its peak.
During the past year, Catalyst Pharmaceuticals(CPRX) stock moved between $19.05 at its lowest and $26.58 at its peak.
CPRX News
Catalyst Pharmaceuticals has secured extended U.S. patent exclusivity for its rare disease drug Firdapse until 2035 and launched the muscle disorder therapy Aga...
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.